openPR Logo
Press release

External Ventricular Drain Market Is Expected To Reach $5.1 Billion by 2031, Growth at CAGR of 7.3% between 2021-2031

External Ventricular Drain Market Is Expected To Reach $5.1

According to a new market research report published by sheer analytics and insights, “The Global External Ventricular Drain Market was valued at $5.1 Billion in 2020. Growing at a high CAGR of more than 7.3% between 2021 and 2031, it is estimated to reach $11.3 Billion by 2031”, as per the latest market research report titled, Global External Ventricular Drain Market - industry analysis, size, share, growth, trends and forecast, 2031 – 2031.

Get Sample Copy With Covid19 Impact Analysis: https://www.sheeranalyticsandinsights.com/request-sample/external-ventricular-drain-market-21

Increased incidences of neurological disorders and the increased road accidents resulting in traumatic brain injuries are the main factors that will help to accelerate the growth of this market during the forecasted period. Also, the increased research activities and the increased adoption of technologically advanced products also help the market to grow during the forecasted period.

Geographically, The Global External Ventricular Drain Market is divided into global regions like North America, Europe, Asia- Pacific, Latin America, Middle East, and Africa.

The primary key players in Global External Ventricular Drain Market include Spiegelberg GmbH & Co. KG, Medtronic, Sophysa, Dispomedica GmbH, Integra LifeSciences, Möller Medical GmbH, B. Braun Melsungen AG, Fuji Systems, Zebra Medical, Neuromedex GmbH, Pfizer Inc., Cadila Pharmaceuticals, R.N. Laboratories Pvt. Ltd., Healthy Life Pharma., Geistlich Pharma Inc.

Browse The Full Report at https://www.sheeranalyticsandinsights.com/market-report-research/external-ventricular-drain-market-21

The Global External Ventricular Drain Market Has Been Segmented Into:

By Product Type
• Ventricular Drainage Set
• Accessories

By Application Type
• Hydrocephalus
• Reye Syndrome
• Traumatic Brain Injury
• Subarachnoid Hemorrhage
• Intracerebral Hemorrhage
• Other Non-traumatic Hydrocephalus Conditions

By End-Use Type
• Hospitals
• Specialty Hospitals
• Specialty Clinics
• Others

By Region
• North America
o USA
o Canada
o Mexico
o Rest of North America
• Europe
o UK
o Germany
o France
o Spain
o Italy
o Russia
o Rest of Europe
• Asia Pacific
o India
o China
o Japan
o South Korea
o Rest of Asia Pacific
• Latin America, Middle East & Africa
o Brazil
o South Africa
o UAE
o Rest of LAMEA

Download Free PDF Sample Request: https://www.sheeranalyticsandinsights.com/request-sample/external-ventricular-drain-market-21

Contact us:
Name: Abhigyan Sengupta
(Global Sales Manager)
Ph.: +1-414-240-5010 (U.S.)
Email: sales@sheeranalyticsandinsights.com
Website: https://www.sheeranalyticsandinsights.com/
Follow Us on LinkedIn: https://www.linkedin.com/company/sheeranalyticsandinsightsprivatelimited/

About Us:
Sheer Analytics and Insights as the firm is created to balance client requirements without compromising the core values of Market research in –terms of quality, factual correctness, market awareness, and analysis. SAI goes back to the root of Market Research in terms of TAM (Total Available Market) and PAM (Potential Available Market) and assess the same quantifying all Push and Pull factors.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release External Ventricular Drain Market Is Expected To Reach $5.1 Billion by 2031, Growth at CAGR of 7.3% between 2021-2031 here

News-ID: 2243232 • Views:

More Releases from Sheer Analytics and Insights

Oligonucleotide Synthesis Market is Expected to Reach $19.8 billion by 2032
Oligonucleotide Synthesis Market is Expected to Reach $19.8 billion by 2032
According to a market report, published by Sheer Analytics and Insights, The global oligonucleotide synthesis market was valued at $3.4 billion in 2021 and it is expected to reach $19.8 billion at a CAGR of 17.1% between 2022 and 2032. Revenue generation in this market is expected to expand as a result of the recent success of oligonucleotide-based medications in medicine as a result of an increase in the number
Global Hyperspectral Imaging Market is Expected to Reach US$ 732.2 million by 2032
Global Hyperspectral Imaging Market is Expected to Reach US$ 732.2 million by 20 …
According to a market report, published by Sheer Analytics and Insights, The global hyperspectral imaging market was valued at $171.2 million in 2021 and it is expected to reach $732.2 million at a CAGR of 13.20% between 2022 and 2032. The human eye has only three color receptors such as green, blue, and red. Hyperspectral imaging measures the continuous spectrum of the light for each pixel of the scene with
Hyperautomation Market is expected to grow at 21.7% CAGR between 2021-2031
Hyperautomation Market is expected to grow at 21.7% CAGR between 2021-2031
According to a new market research report published by sheer analytics and insights, "The Global Hyperautomation Market was valued at $4.78 Billion in 2020. Growing at a high CAGR of more than 21.7% between 2021 and 2031, it is estimated to reach $46.4 Billion by 2031", as per the latest market research report titled Global Hyperautomation Market - Industry analysis, size, share, growth, trends and forecast, 2021 - 2031. According to
Systemic Scleroderma Treatment Market to Expand at 8.06% CAGR and Reach US$ 4.3 Billion by 2031
Systemic Scleroderma Treatment Market to Expand at 8.06% CAGR and Reach US$ 4.3 …
According to a new market research report published by sheer analytics and insights, “The Global Systemic Scleroderma Treatment Market was valued at $1.80 Billion in 2020. Growing at a high CAGR of more than 8.06% between 2021 and 2031, it is estimated to reach $4.3 Billion by 2031", as per the latest market research report titled Global Systemic Scleroderma Treatment Market - Industry analysis, size, share, growth, trends and forecast,

All 4 Releases


More Releases for Ventricular

Evolving Market Trends In The Left Ventricular Assist Devices Industry: Advancem …
The Left Ventricular Assist Devices Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Left Ventricular Assist Devices Market Size During the Forecast Period? In recent times, the market size for left ventricular assist devices has experienced considerable growth. The projections reveal an
Key Trends Shaping the Future Ventricular Fibrillation Market From 2025-2034: Te …
What Is the Estimated Market Size and Growth Rate for the Ventricular Fibrillation Market? In recent years, there has been a significant growth in the market size of ventricular fibrillation. The market, which is projected to expand from $6.13 billion in 2024 to $6.53 billion in 2025, is set to achieve a compound annual growth rate (CAGR) of 6.6%. Factors such as heightened awareness, a spike in heart-related conditions, advancements
Ventricular Assist Device Market - Supporting Hearts, Restoring Hope: Leading th …
Newark, New Castle, USA: The "Ventricular Assist Device Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Ventricular Assist Device Market: https://www.growthplusreports.com/report/ventricular-assist-device-market/7893 This latest report researches the industry structure,
Ventricular Assist Device Market - Embracing Life, Empowering Hearts: Redefining …
Newark, New Castle, USA - new report, titled Ventricular Assist Device Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Ventricular Assist Device market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Ventricular Assist Device market. The report offers an overview of
Ventricular Assist Device Market Forecast to 2032 - Covid-19 Impact and Global A …
Report Overview The global ventricular assist device market size was valued at USD 1.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 17.6% from 2023 to 2032. The increased prevalence of chronic conditions such diabetes, neurological disorders, cardiovascular diseases, hypertension, and stroke, as well as the expanding worldwide elderly population, are some of the key drivers that are projected to fuel demand for
05-08-2017 | Health & Medicine
SA-BRC
Ventricular Assist Devices (VAD) Market Assessment
Ventricular assist devices (VAD) are mechanical pumps used to support patients with a weakened heart or in case of heart failure to temporarily maintain heart function. The devices helps in re-establishing normal hemodynamics under conditions involving damaged ventricle. Increasing trend for sedentary lifestyle, rising obesity population globally, lifestyle changes and various other factors have resulted an increase in cardiovascular disorders. This rising prevalence across the globe has been a major